Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G/A for Jade Biosciences, Inc. Common Stock, $0.0001 par value per share (JBIO).
- Disclosed ownership: 7%.
- Date of event: 30 Sep 2025.
Deep Track Capital, LP - 30 Sep 2025 SCHEDULE 13G/A Report for Jade Biosciences, Inc. Common Stock, $0.0001 par value per share (JBIO)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- JBIO
- Shares outstanding
- 32,616,481 shares
- Disclosed Ownership
- 2,279,892 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 08:18:20 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 20 Jun 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 7% ownership in Jade Biosciences, Inc. Common Stock, $0.0001 par value per share (JBIO) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 20 Jun 2025.
- Current filing was accepted on 14 Nov 2025, 08:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 7% | 2,279,892 | 0 | 2,279,892 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 7% | 2,279,892 | 0 | 2,279,892 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 7% | 2,279,892 | 0 | 2,279,892 | /s/ David Kroin | David Kroin |